Responses
Regular and Young Investigator Award Abstracts
Regulatory, Financial and Access Considerations
1430 Development of ICTIS: a novel scoring system for the inclusivity of advanced non-small-cell lung cancer immunotherapy clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.